Fluticasone Furoate (100mcg) + Umeclidinium (62.5mcg) + Vilanterol (25mcg) Inhaler
Description
Trelegy Ellipta Inhaler | Clinical Information, Safety & Product Overview
Description:
Trelegy Ellipta Inhalation Powder: Get Trelegy Ellipta Inhalation Powder product information, active ingredients, drug action, safety, storage, and frequently asked questions for healthcare professionals.
Trelegy Ellipta Inhaler – Information
Trelegy Ellipta is a prescription inhaled drug that contains 3 medicines in 1 inhaler for the long-term maintenance treatment of certain chronic respiratory diseases. It is to be used only under the supervision of a qualified healthcare professional and in accordance with the approved prescribing guidelines.
Product Summary:
Trelegy Ellipta is a dry powder inhaler that delivers three medicines that work together, in one inhaler. This formulation is appropriate for maintenance therapy over the long-term and should not be used as a rescue inhaler for acute breathing problems.
Active Components:
Fluticasone Furoate – Inhaled corticosteroid (ICS)
Umeclidinium - Long-acting muscarinic antagonist (LAMA)
Vilanterol — Long-acting beta2-agonist (LABA)
Main Features
Triple inhaler
Maintenance therapy once daily
single device inhaler
Intended for chronic respiratory management
medication on prescription
Easy to use inhalation device
How it functions:
Trelegy Ellipta is a mixture of three drugs that collectively operate in different ways:
Fluticasone Furoate reduces inflammation in the airways.
Umeclidinium relaxes muscles of the airways and blocks muscarinic receptors, helping to keep the airways open .
Vilanterol acts by stimulating beta2 receptors in the lungs to relax the muscles of the airways, improving airflow.
These acts, when taken frequently as directed, work together to assist sustain improved breathing.
FAQS
1. What is Trelegy Ellipta for?
Trelegy Ellipta is a prescription medicine used as a maintenance treatment to help control symptoms of some long-term lung diseases.
2. Is Trelegy Ellipta a rescue medication?
No. It is for long-term maintenance treatment and should not be used instead of a quick-acting rescue inhaler when you have unexpected breathing issues.
3. Can Trelegy Ellipta be stopped once symptoms improve?
No. Trelegy Ellipta is a long-term maintenance medicine and should not be discontinued or the dosage changed without consulting a qualified healthcare professional. Stopping treatment without medical advice may lead to worsening control of the underlying respiratory condition. Always follow your healthcare provider's recommendations regarding the duration and continuation of therapy.
4. What are the ingredients?
Trelegy Ellipta includes fluticasone furoate, umeclidinium and vilanterol.
5. How to store inhaler?
Store as recommended by the manufacturer, in original packaging and protect from excess moisture and heat.
Ernest Impex - Export Company of India Contact Details
(Ernest Pharmaceutical Pvt. Ltd. A Division of)
Contact Ernest Impex - Pharmaceutical Exporter of India
(A group of Ernest Pharmaceutical Pvt. Ltd.)
🌐 Websites:
www.ernestimpex.com www.ernestvision.com
www.oncologymedicinesupplier.com
www.ernestpharmaceuticals.com
📧 Email: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383 / https://wa.me/919359902383
